Nursing homes should be permitted to hold a central stock of anticipatory end-of-life medication

Nursing homes should be permitted to hold a central stock of anticipatory end-of-life medications for use when prescribed and clinically indicated for any service user. This would enable rapid symptom control, prevent distress caused by delays in accessing medication, and reduce unnecessary hospital admissions at the end of life. Timely access to these medications supports compassionate, person-centred care and allows individuals to remain in their preferred place of care.